Asthma control in NYUBAR groups (N = 471).
收藏NIAID Data Ecosystem2026-03-07 收录
数据链接：
官方服务：
资源简介：
Data missing for daytime symptoms on 1 subject, nocturnal symptoms in 2 subjects, SABA use in 15 subjects, functional status on 12 subjects. †Only 2 subjects used omalizumab: 1 in Group 2 and 1 in Group 3. *Non-ICS controller includes theophylline, leukotriene inhibitors, cromolyn and LABA. **other controller includes theophylline, leukotriene inhibitors, and cromolyn.
创建时间：
2012-09-13
